Literature DB >> 34126238

m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options.

Sabrina Garbo1, Clemens Zwergel2, Cecilia Battistelli3.   

Abstract

m6A is emerging as one of the most important RNA modifications because of its involvement in pathological and physiological events. Here, we provide an overview of this epitranscriptomic modification, beginning with a description of the molecular players involved and continuing with a focus on the role of m6A in the maintenance of stemness, induction of the epithelial to mesenchymal transition (EMT), and tumor progression. Finally, we discuss the state of the art regarding the design and validation of inhibitors of m6A writers or erasers to provide a background for future investigations and for the development of specific therapeutics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Epitranscriptomics; METTL3; RNA; m6A

Mesh:

Substances:

Year:  2021        PMID: 34126238     DOI: 10.1016/j.drudis.2021.06.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  8 in total

1.  METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.

Authors:  Huafu Li; Chunming Wang; Linxiang Lan; Leping Yan; Wuguo Li; Ian Evans; E Josue Ruiz; Qiao Su; Guangying Zhao; Wenhui Wu; Haiyong Zhang; Zhijun Zhou; Zhenran Hu; Wei Chen; Joaquim M Oliveira; Axel Behrens; Rui L Reis; Changhua Zhang
Journal:  Cell Mol Life Sci       Date:  2022-02-18       Impact factor: 9.261

2.  The Alteration of m6A Modification at the Transcriptome-Wide Level in Human Villi During Spontaneous Abortion in the First Trimester.

Authors:  Jiajie She; Kaifen Tan; Jie Liu; Shuo Cao; Zengguang Li; You Peng; Zhuoyu Xiao; Ruiying Diao; Liping Wang
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 3.  Multiple roles of m6A methylation in epithelial-mesenchymal transition.

Authors:  Xueru Zhao; Xue Li; Xiaohua Li
Journal:  Mol Biol Rep       Date:  2022-03-20       Impact factor: 2.742

4.  Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N 6-Methyladenosine-Modified RNAs.

Authors:  Mariachiara Micaelli; Andrea Dalle Vedove; Linda Cerofolini; Jacopo Vigna; Denise Sighel; Sara Zaccara; Isabelle Bonomo; Georgios Poulentzas; Emanuele Filiberto Rosatti; Giulia Cazzanelli; Laura Alunno; Romina Belli; Daniele Peroni; Erik Dassi; Shino Murakami; Samie R Jaffrey; Marco Fragai; Ines Mancini; Graziano Lolli; Alessandro Quattrone; Alessandro Provenzani
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-14

5.  m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma.

Authors:  Jing Wang; Wentao Wang; Xing Huang; Jiashi Cao; Shuming Hou; Xiangzhi Ni; Cheng Peng; Tielong Liu
Journal:  J Bone Oncol       Date:  2022-01-19       Impact factor: 4.072

Review 6.  Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy.

Authors:  Su Zhang; Yang Meng; Lian Zhou; Lei Qiu; Heping Wang; Dan Su; Bo Zhang; Kui-Ming Chan; Junhong Han
Journal:  MedComm (2020)       Date:  2022-09-15

7.  microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition.

Authors:  Bingfeng Luo; Yuan Yuan; Yifei Zhu; Songwu Liang; Runan Dong; Jian Hou; Ping Li; Yaping Xing; Zhenquan Lu; Richard Lo; Guan-Ming Kuang
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

8.  N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.

Authors:  Wei Song; Jun Ren; Wenzheng Yuan; Rensheng Xiang; Yuhang Ge; Tao Fu
Journal:  Genes (Basel)       Date:  2021-08-31       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.